Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

STRENSIQ - Health Canada Drug Approval Details

Approvals/Health Canada/STRENSIQ

Authorized

STANDARD

STRENSIQ

Alexion Pharma GmbH🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 3fec162d5f8ccbe2
Company: Alexion Pharma GmbH
Type: Standard

Approval Details

Approval Id: 3fec162d5f8ccbe2
Drug Approval Canada Name: STRENSIQ
Product Name: STRENSIQ
Status: Marketed
Status Date: 2016-06-01
Original Market Date: 2016-06-01
Din: 02444631
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 44:00.00
Atc Original: A16AB13 ASFOTASE ALFA
Atc Name: a 16 ab 13
Aig Number: 0157271001
Company Name: Alexion Pharma GmbH
Company Address: Neuhofstrasse 34, Baar, --, Switzerland, 6340
Company Detail Path: /organization/alexion-pharma-gmbh

Company Information

Pharmaceutical Company Name: Alexion Pharma GmbH
Country Name: Switzerland
Province Name: Zug
City Name: baar,zug,country_ch
Address: Neuhofstrasse 34

Active Ingredients

ASFOTASE ALFA

40 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3fec162d5f8ccbe2

Type

Standard

Back to Health Canada Approvals